More tools:Markets·Screener·Research·Chat

Allarity Therapeutics, Inc. Common Stock (ALLR) Financial Statements

Allarity Therapeutics, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG012NXCZQ7
XNAS · usd
1.28▲ 0.02 (2.00%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close1.25
Day's Range1.25 – 1.37
52-Week Range0.77 – 2.06
Volume234.5K
Avg Volume81.7K
Share Statistics
Shares Outstanding
Employees8
ExchangeXNAS
Listed2021-12-21
Share count as of August 14, 2026
Loading Income Statement…
Key questions about Allarity Therapeutics, Inc. Common Stock (ALLR)
What is Allarity Therapeutics, Inc. Common Stock's Market Cap?
Allarity Therapeutics, Inc. Common Stock's Market Cap is $20.3M, based on as-reported figures from SEC (XBRL) filings.
What is Allarity Therapeutics, Inc. Common Stock's Enterprise Value?
Allarity Therapeutics, Inc. Common Stock's Enterprise Value is $24.2M, based on as-reported figures from SEC (XBRL) filings.
What is Allarity Therapeutics, Inc. Common Stock's Price / Sales?
Allarity Therapeutics, Inc. Common Stock's Price / Sales is 58.8×, based on as-reported figures from SEC (XBRL) filings.
What is Allarity Therapeutics, Inc. Common Stock's EV / Revenue?
Allarity Therapeutics, Inc. Common Stock's EV / Revenue is 70.0×, based on as-reported figures from SEC (XBRL) filings.
What is Allarity Therapeutics, Inc. Common Stock's Revenue (TTM)?
Allarity Therapeutics, Inc. Common Stock's Revenue (TTM) is $345.0K, based on as-reported figures from SEC (XBRL) filings.
What is Allarity Therapeutics, Inc. Common Stock's Net Income (TTM)?
Allarity Therapeutics, Inc. Common Stock's Net Income (TTM) is -$12.3M, based on as-reported figures from SEC (XBRL) filings.
What is Allarity Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?
Allarity Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.78, based on as-reported figures from SEC (XBRL) filings.
What is Allarity Therapeutics, Inc. Common Stock's Net Debt?
Allarity Therapeutics, Inc. Common Stock's Net Debt is $3.9M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Revenue——
Operating expenses:
Research and development
General and administrative
Total operating expenses
% of revenue—10852.0%——
Loss from operations
% of revenue—-10752.0%——
Other income (expense):
Interest income
Interest expense
Foreign exchange gains (losses)
Change in fair value of derivative and warrant liabilities
Total other income (expense), net
Net loss
% of revenue—-11000.0%——
Net loss per common share, basic and diluted (in dollars per share)